Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
2023 · Scientific Reports · 23 citations
https://doi.org/10.1038/s41598-023-37468-4
P
Petra Pokorná
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
610
Citations
9
h-index
7
i10-index
Petra Pokorná is an academic researcher from Central European Institute of Technology. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer Genomics and Diagnostics & RNA modifications and cancer. The author has an h-index of 9, co-authored 41 publications.
ORCID: 0000-0003-1037-878XPapers by this author
worksTazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
2023 · Scientific Reports · 15 citations
https://doi.org/10.1038/s41598-023-48774-2
crossNN is an explainable framework for cross-platform DNA methylation-based classification of tumors
2025 · Nature Cancer · 9 citations
https://doi.org/10.1038/s43018-025-00976-5
Analysis of mutations in precision oncology using the automated, accurate, and user-friendly web tool PredictONCO
2024 · Computational and Structural Biotechnology Journal · 1 citations
https://doi.org/10.1016/j.csbj.2024.11.026
Diagnostic efficacy and clinical utility of whole-exome sequencing in Czech pediatric patients with rare and undiagnosed diseases
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-79872-4
Individualized therapeutic approaches for relapsed and refractory pediatric ependymomas: a single institution experience
2025 · Journal of Neuro-Oncology · 0 citations
https://doi.org/10.1007/s11060-025-05004-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat